Evanson Asset Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Evanson Asset Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-22,000	Closed	-$38K	–	223
2016 Q3	$38K	Sell	22,000 -4,000	-15%	-$4.87K	0.01%	201
2016 Q2	$21K	Buy	26,000 +4,000	+18%	+$3.1K	0.01%	201
2016 Q1	$20K	Hold	22,000	–	–	0.01%	197
2015 Q4	$24K	Buy	+22,000	New	+$47.1K	0.01%	198

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWS

AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return

Evanson Asset Management's MBII Position: Q4 2016 in Review

Evanson Asset Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2016, closing a stake of 22,000 shares — an estimated $38K sold.

Evanson Asset Management first reported a position in MBII in Q4 2015 and held it in 4 quarters. The position peaked at $38K in Q3 2016. 23 funds tracked by Wall St. Rank hold MBII as of Q4 2016.

Evanson Asset Management reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2016 after selling out during the quarter.
Evanson Asset Management sold 22,000 Marrone Bio Innovations, Inc. shares in Q4 2016, an estimated $38K.
Evanson Asset Management first reported a position in Marrone Bio Innovations, Inc. in Q4 2015 and held it in 4 quarters.
Evanson Asset Management's Marrone Bio Innovations, Inc. position peaked at $38K in Q3 2016.
23 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2016.

Based on Evanson Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.